A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade Gliomas

NCT05082493 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

High Grade Glioma

Interventions

DRUG: Berubicin Hydrochloride

Sponsor

WPD Pharmaceuticals Sp. z o.o.

Collaborators

[object Object]